TET1 and metabolic dysfunction-associated steatotic liver disease: Likewise, the drugs that activate PPAR-α through hydroxymethylation such as the ten-eleven translocation-1 (TET1) enzyme exerted protective effects against NAFLD, stimulated FA oxidation, and suppressed triglyceride accumulation in the liver [37].